IBM developed a new AI that helps predict the progression of Parkinson’s disease

The application of AI in the medical field is becoming more and more extensive. For example, AI can be used to assist in the diagnosis of cancer or eye diseases, judge the mental health of patients, etc., and can even be used to find the appropriate ingredients of new drugs. Recently, AI has added another purpose to the fight against disease, which is to predict the possible evolution of Parkinson’s disease in different patients.

This new AI was jointly developed by IBM, a world-renowned IT company, and a foundation dedicated to finding a suitable method for the treatment of Parkinson’s disease. In the paper jointly published by the two, they stated that this new AI can predict the different patients, the different time of onset, and the severity of Parkinson’s disease, allowing doctors to better predict the condition of Parkinson’s patients, thus completely changing the way doctors help patients manage symptoms.

This new breakthrough of IBM is based on research called Parkinson’s Progression Markers Initiative. This study has data on more than 1,400 patients. Through this study, IBM has allowed this AI model to depict the complex symptoms and development patterns of Parkinson’s disease.

It is estimated that more than 6 million people worldwide suffer from Parkinson’s disease, and there is currently no treatment for this disease. The new AI developed by IBM this time is expected to provide more detailed and clear feature indicators for different stages of Parkinson’s disease.